The global Oligo Synthesis Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oligo Synthesis Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oligo Synthesis Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Oligo Synthesis Service in Biotech Company is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Oligo Synthesis Service include Thermo Fisher Scientific, GENEWIZ, Genscript, Abace Biotechnology, Tsingke, Sangon Biotech, Shanghai Genecore BioTechnologies, Atantares and Wuhan GeneCreate Biological Engineering, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oligo Synthesis Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligo Synthesis Service.
Report Scope
The Oligo Synthesis Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oligo Synthesis Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligo Synthesis Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Thermo Fisher Scientific
GENEWIZ
Genscript
Abace Biotechnology
Tsingke
Sangon Biotech
Shanghai Genecore BioTechnologies
Atantares
Wuhan GeneCreate Biological Engineering
Beyotime
General Biol
Beijing Biomed
Takara
Biosune
Beijing Dingguo Changsheng Biotechnology
Integrated DNA Technologies (IDT)
Cusabio
Macrogen Europe BV
Synbio Technologies
Segment by Type
Common Primer Synthesis
Modified Primer Synthesis
Segment by Application
Biotech Company
Academic Scientific Research Institution
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oligo Synthesis Service companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Oligo Synthesis Service 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Common Primer Synthesis
1.2.3 Modified Primer Synthesis
1.3 麻豆原创 by Application
1.3.1 Global Oligo Synthesis Service 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotech Company
1.3.3 Academic Scientific Research Institution
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oligo Synthesis Service 麻豆原创 Perspective (2019-2030)
2.2 Oligo Synthesis Service Growth Trends by Region
2.2.1 Global Oligo Synthesis Service 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oligo Synthesis Service Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Oligo Synthesis Service Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Oligo Synthesis Service 麻豆原创 Dynamics
2.3.1 Oligo Synthesis Service Industry Trends
2.3.2 Oligo Synthesis Service 麻豆原创 Drivers
2.3.3 Oligo Synthesis Service 麻豆原创 Challenges
2.3.4 Oligo Synthesis Service 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oligo Synthesis Service Players by Revenue
3.1.1 Global Top Oligo Synthesis Service Players by Revenue (2019-2024)
3.1.2 Global Oligo Synthesis Service Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Oligo Synthesis Service 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oligo Synthesis Service Revenue
3.4 Global Oligo Synthesis Service 麻豆原创 Concentration Ratio
3.4.1 Global Oligo Synthesis Service 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oligo Synthesis Service Revenue in 2023
3.5 Oligo Synthesis Service Key Players Head office and Area Served
3.6 Key Players Oligo Synthesis Service Product Solution and Service
3.7 Date of Enter into Oligo Synthesis Service 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Oligo Synthesis Service Breakdown Data by Type
4.1 Global Oligo Synthesis Service Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Oligo Synthesis Service Forecasted 麻豆原创 Size by Type (2025-2030)
5 Oligo Synthesis Service Breakdown Data by Application
5.1 Global Oligo Synthesis Service Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Oligo Synthesis Service Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Oligo Synthesis Service 麻豆原创 Size (2019-2030)
6.2 North America Oligo Synthesis Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oligo Synthesis Service 麻豆原创 Size by Country (2019-2024)
6.4 North America Oligo Synthesis Service 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oligo Synthesis Service 麻豆原创 Size (2019-2030)
7.2 Europe Oligo Synthesis Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oligo Synthesis Service 麻豆原创 Size by Country (2019-2024)
7.4 Europe Oligo Synthesis Service 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oligo Synthesis Service 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Oligo Synthesis Service 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oligo Synthesis Service 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Oligo Synthesis Service 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oligo Synthesis Service 麻豆原创 Size (2019-2030)
9.2 Latin America Oligo Synthesis Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oligo Synthesis Service 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Oligo Synthesis Service 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oligo Synthesis Service 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Oligo Synthesis Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oligo Synthesis Service 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Oligo Synthesis Service 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Oligo Synthesis Service Introduction
11.1.4 Thermo Fisher Scientific Revenue in Oligo Synthesis Service Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 GENEWIZ
11.2.1 GENEWIZ Company Detail
11.2.2 GENEWIZ Business Overview
11.2.3 GENEWIZ Oligo Synthesis Service Introduction
11.2.4 GENEWIZ Revenue in Oligo Synthesis Service Business (2019-2024)
11.2.5 GENEWIZ Recent Development
11.3 Genscript
11.3.1 Genscript Company Detail
11.3.2 Genscript Business Overview
11.3.3 Genscript Oligo Synthesis Service Introduction
11.3.4 Genscript Revenue in Oligo Synthesis Service Business (2019-2024)
11.3.5 Genscript Recent Development
11.4 Abace Biotechnology
11.4.1 Abace Biotechnology Company Detail
11.4.2 Abace Biotechnology Business Overview
11.4.3 Abace Biotechnology Oligo Synthesis Service Introduction
11.4.4 Abace Biotechnology Revenue in Oligo Synthesis Service Business (2019-2024)
11.4.5 Abace Biotechnology Recent Development
11.5 Tsingke
11.5.1 Tsingke Company Detail
11.5.2 Tsingke Business Overview
11.5.3 Tsingke Oligo Synthesis Service Introduction
11.5.4 Tsingke Revenue in Oligo Synthesis Service Business (2019-2024)
11.5.5 Tsingke Recent Development
11.6 Sangon Biotech
11.6.1 Sangon Biotech Company Detail
11.6.2 Sangon Biotech Business Overview
11.6.3 Sangon Biotech Oligo Synthesis Service Introduction
11.6.4 Sangon Biotech Revenue in Oligo Synthesis Service Business (2019-2024)
11.6.5 Sangon Biotech Recent Development
11.7 Shanghai Genecore BioTechnologies
11.7.1 Shanghai Genecore BioTechnologies Company Detail
11.7.2 Shanghai Genecore BioTechnologies Business Overview
11.7.3 Shanghai Genecore BioTechnologies Oligo Synthesis Service Introduction
11.7.4 Shanghai Genecore BioTechnologies Revenue in Oligo Synthesis Service Business (2019-2024)
11.7.5 Shanghai Genecore BioTechnologies Recent Development
11.8 Atantares
11.8.1 Atantares Company Detail
11.8.2 Atantares Business Overview
11.8.3 Atantares Oligo Synthesis Service Introduction
11.8.4 Atantares Revenue in Oligo Synthesis Service Business (2019-2024)
11.8.5 Atantares Recent Development
11.9 Wuhan GeneCreate Biological Engineering
11.9.1 Wuhan GeneCreate Biological Engineering Company Detail
11.9.2 Wuhan GeneCreate Biological Engineering Business Overview
11.9.3 Wuhan GeneCreate Biological Engineering Oligo Synthesis Service Introduction
11.9.4 Wuhan GeneCreate Biological Engineering Revenue in Oligo Synthesis Service Business (2019-2024)
11.9.5 Wuhan GeneCreate Biological Engineering Recent Development
11.10 Beyotime
11.10.1 Beyotime Company Detail
11.10.2 Beyotime Business Overview
11.10.3 Beyotime Oligo Synthesis Service Introduction
11.10.4 Beyotime Revenue in Oligo Synthesis Service Business (2019-2024)
11.10.5 Beyotime Recent Development
11.11 General Biol
11.11.1 General Biol Company Detail
11.11.2 General Biol Business Overview
11.11.3 General Biol Oligo Synthesis Service Introduction
11.11.4 General Biol Revenue in Oligo Synthesis Service Business (2019-2024)
11.11.5 General Biol Recent Development
11.12 Beijing Biomed
11.12.1 Beijing Biomed Company Detail
11.12.2 Beijing Biomed Business Overview
11.12.3 Beijing Biomed Oligo Synthesis Service Introduction
11.12.4 Beijing Biomed Revenue in Oligo Synthesis Service Business (2019-2024)
11.12.5 Beijing Biomed Recent Development
11.13 Takara
11.13.1 Takara Company Detail
11.13.2 Takara Business Overview
11.13.3 Takara Oligo Synthesis Service Introduction
11.13.4 Takara Revenue in Oligo Synthesis Service Business (2019-2024)
11.13.5 Takara Recent Development
11.14 Biosune
11.14.1 Biosune Company Detail
11.14.2 Biosune Business Overview
11.14.3 Biosune Oligo Synthesis Service Introduction
11.14.4 Biosune Revenue in Oligo Synthesis Service Business (2019-2024)
11.14.5 Biosune Recent Development
11.15 Beijing Dingguo Changsheng Biotechnology
11.15.1 Beijing Dingguo Changsheng Biotechnology Company Detail
11.15.2 Beijing Dingguo Changsheng Biotechnology Business Overview
11.15.3 Beijing Dingguo Changsheng Biotechnology Oligo Synthesis Service Introduction
11.15.4 Beijing Dingguo Changsheng Biotechnology Revenue in Oligo Synthesis Service Business (2019-2024)
11.15.5 Beijing Dingguo Changsheng Biotechnology Recent Development
11.16 Integrated DNA Technologies (IDT)
11.16.1 Integrated DNA Technologies (IDT) Company Detail
11.16.2 Integrated DNA Technologies (IDT) Business Overview
11.16.3 Integrated DNA Technologies (IDT) Oligo Synthesis Service Introduction
11.16.4 Integrated DNA Technologies (IDT) Revenue in Oligo Synthesis Service Business (2019-2024)
11.16.5 Integrated DNA Technologies (IDT) Recent Development
11.17 Cusabio
11.17.1 Cusabio Company Detail
11.17.2 Cusabio Business Overview
11.17.3 Cusabio Oligo Synthesis Service Introduction
11.17.4 Cusabio Revenue in Oligo Synthesis Service Business (2019-2024)
11.17.5 Cusabio Recent Development
11.18 Macrogen Europe BV
11.18.1 Macrogen Europe BV Company Detail
11.18.2 Macrogen Europe BV Business Overview
11.18.3 Macrogen Europe BV Oligo Synthesis Service Introduction
11.18.4 Macrogen Europe BV Revenue in Oligo Synthesis Service Business (2019-2024)
11.18.5 Macrogen Europe BV Recent Development
11.19 Synbio Technologies
11.19.1 Synbio Technologies Company Detail
11.19.2 Synbio Technologies Business Overview
11.19.3 Synbio Technologies Oligo Synthesis Service Introduction
11.19.4 Synbio Technologies Revenue in Oligo Synthesis Service Business (2019-2024)
11.19.5 Synbio Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher Scientific
GENEWIZ
Genscript
Abace Biotechnology
Tsingke
Sangon Biotech
Shanghai Genecore BioTechnologies
Atantares
Wuhan GeneCreate Biological Engineering
Beyotime
General Biol
Beijing Biomed
Takara
Biosune
Beijing Dingguo Changsheng Biotechnology
Integrated DNA Technologies (IDT)
Cusabio
Macrogen Europe BV
Synbio Technologies
听
听
*If Applicable.
